IDIOPATHIC PARKINSON DISEASE
Clinical trials for IDIOPATHIC PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for IDIOPATHIC PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supplements show promise for Parkinson's brain health
Disease control CompletedThis study looked at whether nutritional supplements, specifically N-acetyl cysteine (NAC), could support brain function in people with Parkinson's disease. 51 participants were randomly assigned to receive NAC (orally and intravenously), standard care, or other oral supplements.…
Matched conditions: IDIOPATHIC PARKINSON DISEASE
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 05:34 UTC
-
New drug VTX3232 tested for safety in early Parkinson's patients
Symptom relief CompletedThis study tested whether a drug called VTX3232 is safe for people with early-stage Parkinson's disease. Eleven participants took the drug for 28 days and were monitored for side effects. The goal was to check safety and how the drug moves through the body, not to cure the diseas…
Matched conditions: IDIOPATHIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Zomagen Biosciences Ltd. • Aim: Symptom relief
Last updated May 26, 2026 05:24 UTC